Janete F. Guardia

FDA investigator

Appears on 4 documents from 2016 to 2023, mostly at sites in China. Most often cites general requirements (21 CFR 211.160).

4
Documents on file
6.3
Observations per 483
2016
First seen
2023
Most recent

What they cite most

From 25 observations

Activity by year

2016: 1, 2023: 3

Where

China 3 · Texas 1

Is Janete F. Guardia coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Nanchang Anobri Pharmaceutical CO., LTD Building B1, No. 888, Jingkai AvenueNov 21, 2023 · Nanchang City, China
483 Nanchang Anobri Pharmaceuticals Co., LtdNov 21, 2023 · Nanchang, China
483 Ming Fai Industrial (Shenzhen) Co., Ltd.Mar 10, 2023 · Shenzhen, China
483 Simpro, LLCJul 7, 2016 · Irving, Texas

About this profile

What does Janete F. Guardia inspect?

Janete F. Guardia appears on 4 documents on file covering 3 sites, mostly in China.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 820.30 and 21 CFR 211.22(d).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Janete F. Guardia is dated Nov 21, 2023.